4 December 2015 - Deborah Wilkes
Archived
Meda is divesting Euromed – its business-to-business manufacturer of herbal extracts and natural active substances – to private-equity firm The Riverside Company for €82 million (US$89 million) in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.